- Home
- TARS vs IVT Comparison
TARS vs IVT Comparison
Compare TARS & IVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TARS | IVT |
|---|---|---|
| Founded | 2016 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.8B |
| IPO Year | 2020 | 2005 |
Fundamental Metrics
Financial Performance| Metric | TARS | IVT |
|---|---|---|
| Price | $59.11 | $36.66 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 7 |
| Target Price | ★ $89.00 | $32.50 |
| AVG Volume (30 Days) | 1.2M | ★ 1.3M |
| Earning Date | 05-06-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 3.14% |
| EPS Growth | 48.21 | ★ 647.37 |
| EPS | N/A | ★ 0.07 |
| Revenue | ★ $451,360,000.00 | $299,169,000.00 |
| Revenue This Year | $56.43 | $8.42 |
| Revenue Next Year | $30.19 | $5.25 |
| P/E Ratio | ★ N/A | $523.43 |
| Revenue Growth | ★ 146.71 | 9.20 |
| 52 Week Low | $38.51 | $26.81 |
| 52 Week High | $85.25 | $36.64 |
Technical Indicators
Market Signals| Indicator | TARS | IVT |
|---|---|---|
| Relative Strength Index (RSI) | 45.93 | 66.90 |
| Support Level | $59.16 | $34.63 |
| Resistance Level | $67.14 | N/A |
| Average True Range (ATR) | 4.27 | 0.65 |
| MACD | -0.78 | 0.01 |
| Stochastic Oscillator | 31.00 | 77.99 |
Price Performance
Historical ComparisonAbout TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.
About IVT InvenTrust Properties Corp.
InvenTrust Properties Corp is the United States of America based company qualified as a REIT (Real Estate Investment Trust). It is focused on owning, leasing, redeveloping, acquiring and managing a multi-tenant retail platform. The company's wholly-owned and managed retail properties include grocery-anchored community and neighborhood centers and power centers, including those classified as necessity-based. InvenTrust operates through a single segment i.e. multi-tenant retail.